1. Home
  2. RDY vs DAN Comparison

RDY vs DAN Comparison

Compare RDY & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDY
  • DAN
  • Stock Information
  • Founded
  • RDY 1984
  • DAN 1904
  • Country
  • RDY India
  • DAN United States
  • Employees
  • RDY N/A
  • DAN N/A
  • Industry
  • RDY Biotechnology: Pharmaceutical Preparations
  • DAN Auto Parts:O.E.M.
  • Sector
  • RDY Health Care
  • DAN Consumer Discretionary
  • Exchange
  • RDY Nasdaq
  • DAN Nasdaq
  • Market Cap
  • RDY 2.1B
  • DAN 2.1B
  • IPO Year
  • RDY N/A
  • DAN N/A
  • Fundamental
  • Price
  • RDY $13.24
  • DAN $12.41
  • Analyst Decision
  • RDY Buy
  • DAN Buy
  • Analyst Count
  • RDY 1
  • DAN 8
  • Target Price
  • RDY $17.00
  • DAN $17.86
  • AVG Volume (30 Days)
  • RDY 1.9M
  • DAN 1.5M
  • Earning Date
  • RDY 05-06-2025
  • DAN 04-29-2025
  • Dividend Yield
  • RDY 3.61%
  • DAN 3.21%
  • EPS Growth
  • RDY 2.68
  • DAN N/A
  • EPS
  • RDY 0.75
  • DAN N/A
  • Revenue
  • RDY $3,637,607,642.00
  • DAN $10,284,000,000.00
  • Revenue This Year
  • RDY $17.23
  • DAN N/A
  • Revenue Next Year
  • RDY $9.19
  • DAN $5.96
  • P/E Ratio
  • RDY $17.94
  • DAN N/A
  • Revenue Growth
  • RDY 14.74
  • DAN N/A
  • 52 Week Low
  • RDY $12.50
  • DAN $7.58
  • 52 Week High
  • RDY $16.89
  • DAN $16.90
  • Technical
  • Relative Strength Index (RSI)
  • RDY 48.34
  • DAN 34.57
  • Support Level
  • RDY $13.09
  • DAN $12.74
  • Resistance Level
  • RDY $13.85
  • DAN $13.78
  • Average True Range (ATR)
  • RDY 0.14
  • DAN 0.59
  • MACD
  • RDY 0.02
  • DAN -0.14
  • Stochastic Oscillator
  • RDY 19.74
  • DAN 7.76

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

Share on Social Networks: